Duopa Suspension
Product Images NDC 0074-3012

116 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 116 technical images submitted to the FDA as part of the official labeling for Duopa (NDC 0074-3012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carbidopa Chem Structure (Duopa 01)

Carbidopa Chem Structure (Duopa 01)
Chemical structure of Carbidopa, the active ingredient in Duopa suspension. It shows the molecular arrangement including phenol groups, hydrazine, and keto functional groups, as well as a water molecule (hydrate).*
FDA Label Image

Levodopa Chem Structure (Duopa 02)

Levodopa Chem Structure (Duopa 02)
Chemical structure of Carbidopa, the active ingredient in Duopa (Carbidopa and Levodopa) suspension. The structure shows a benzene ring with two hydroxyl groups, connected to an amino acid side chain including an amine group and a carboxylic acid group.*
FDA Label Image

Figure 1. Plasma Concentrations (mean ± Standard Deviation) Versus Time Profile Of Levodopa With Duopa (levodopa, 1580 ± 403 mg; Carbidopa, 366 ± 92 mg) 16-hour Infusion (Duopa 03)

Figure 1. Plasma Concentrations (mean ± Standard Deviation) Versus Time Profile Of Levodopa With Duopa (levodopa, 1580 ± 403 mg; Carbidopa, 366 ± 92 mg) 16-hour Infusion (Duopa 03)
A line graph depicting Levodopa plasma concentration (µg/mL) over time (hours). The chart shows fluctuations in plasma levels with error bars indicating variability at each time point, spanning from 0 to 20 hours on the x-axis and 0 to 5 µg/mL on the y-axis.*
FDA Label Image

Figure 2. Change In “off” Time Over 12 Weeks. (Duopa 04)

Figure 2. Change In “off” Time Over 12 Weeks. (Duopa 04)
A line graph comparing the change in ON time (hours) from baseline over a 12-week period for Duopa and oral immediate-release carbidopa-levodopa. The x-axis represents the visit timeline from baseline to week 12, while the y-axis measures the change in ON time in hours. The graph includes sample sizes for each group at each visit.*
FDA Label Image

Duopa(carbidopa And Levodopa) Enteral Suspension (Duopa 05)

Duopa(carbidopa And Levodopa) Enteral Suspension (Duopa 05)
An instructional diagram showing components of the Duopa enteral suspension delivery system by AbbVie Inc. It includes labeled parts such as the pump, Duopa cassette, stomach tube, stoma site, and different connector types with color coding for identification.*
FDA Label Image

Cadd-legacy®-1400 Pump (Duopa 06)

Cadd-legacy®-1400 Pump (Duopa 06)
An instructional diagram of the CADD-Legacy 1400 Pump used with Duopa. The diagram labels key parts including the display, accessory jack, keypad, Duopa cassette, cassette latch on the side, and the battery compartment at the back. It also notes that tubing should not be placed in the indicated slot not used in this application.*
FDA Label Image

Description Of The Keys (Duopa 07)

Description Of The Keys (Duopa 07)
A text panel titled 'Description of the Keys' explaining the functions of various control buttons on a device. It details keys for starting/stopping the pump, saving values, filling tubing with Duopa suspension, delivering morning and extra doses, advancing screens, adjusting values, and low power mode. It notes the PRIME key is for healthcare provider use only.*
FDA Label Image

Battery Status (Duopa 08)

Battery Status (Duopa 08)
An instructional diagram showing the status display for a pump. It illustrates that when running, the pump displays "RUN" along with battery status, with LowBat indicating low battery. When stopped, the pump displays "STOPPED".*
FDA Label Image

Figure-b (Duopa 09)

Figure-b (Duopa 09)
An instructional diagram showing a hand holding a device and inserting or adjusting a component by pulling it outward, with an arrow indicating the direction of movement. The image appears to demonstrate a step related to the use or setup of a device associated with the product Duopa, a carbidopa and levodopa suspension for enteral administration.*
FDA Label Image

Figure-c (Duopa 0a)

Figure-c (Duopa 0a)
An illustration depicting a hand holding a device container with an arrow indicating the action of removing or opening its lid. This diagram is likely instructional, showing how to access or operate the device associated with the Duopa carbidopa and levodopa enteral suspension product.*
FDA Label Image

Figure D (Duopa 0b)

Figure D (Duopa 0b)
An instructional illustration showing a person holding a Duopa enteral suspension pump with one hand while using the other hand to prepare or operate the device, demonstrating device handling or administration technique.*
FDA Label Image

Figure E (Duopa 0c)

Figure E (Duopa 0c)
An instructional illustration showing a close-up of a device with a locked mechanism labeled 'LOCKED.' The image includes arrows indicating a turning motion to unlock or lock components of the device, relevant to the Duopa suspension delivery system.*
FDA Label Image

Figure-f (Duopa 0d)

Figure-f (Duopa 0d)
An instructional illustration showing hands connecting two components of an enteral delivery system, likely demonstrating how to attach parts of a Duopa suspension pump or tubing for administration.*
FDA Label Image

Figure G (Duopa 0e)

Figure G (Duopa 0e)
An instructional illustration labeled Figure G showing two hands assembling a component, likely related to the administration of Duopa enteral suspension. One hand holds a cylindrical device, while the other hand attaches a part resembling a clip or connector.*
FDA Label Image

Figure H (Duopa 0f)

Figure H (Duopa 0f)
An instructional diagram labeled as Figure H showing two hands assembling or connecting parts of a device, possibly related to the administration or packaging of Duopa suspension (carbidopa and levodopa). The image demonstrates how to attach two components together, likely for enteral use.*
FDA Label Image

On Off Button (Duopa 10)

On Off Button (Duopa 10)
An instructional image showing a small device or cap with the label 'ON' and 'OFF' positions, likely representing a switch or control feature associated with the Duopa enteral suspension medication delivery system.*
FDA Label Image

Stopped Screen (Duopa 11)

Stopped Screen (Duopa 11)
A simple text panel displaying the word 'STOPPED' in uppercase letters on a white background with a thin black border. There is no additional visible context or information on the panel.*
FDA Label Image

Figure I (Duopa 12)

Figure I (Duopa 12)
An instructional illustration labeled 'Figure 1' showing two hands manipulating a medical device, with one hand holding a tube and the other hand pulling or adjusting a small part on the tube, likely demonstrating a step in preparing or administering the enteral suspension Duopa (Carbidopa and Levodopa).*
FDA Label Image

Stop-start-button (Duopa 13)

FDA Label Image

Run-screen (Duopa 14)

FDA Label Image

Morning Dose Button (Duopa 15)

Morning Dose Button (Duopa 15)
Duopa 20 mg/mL carbidopa and 4.63 mg/mL levodopa enteral suspension label from AbbVie Inc. The image shows the product name and strengths clearly on a white background with a distinctive black and white graphic of a dog's head and the text "Morning Dose."*
FDA Label Image

Morning Dose Screen (Duopa 16)

Morning Dose Screen (Duopa 16)
A medication administration display screen showing a morning dose entry field labeled 'Morning Dose' with a placeholder for the dose in milliliters (ml), presented as 'x.x ml'.*
FDA Label Image

Figure J (Duopa 17)

Figure J (Duopa 17)
An instructional illustration showing a hand opening or closing a compartment on a rectangular device or container, with an arrow indicating the direction of movement. This appears as a usage or handling guide related to the drug product Duopa suspension by AbbVie Inc.*
FDA Label Image

Figure K (Duopa 18)

Figure K (Duopa 18)
Illustration labeled Figure K shows a person wearing a Duopa enteral suspension pump device suspended from straps around the neck and shoulders. The device is positioned at the chest level, demonstrating proper placement of the portable infusion pump for this prescription drug administration.*
FDA Label Image

Figure L (Duopa 19)

Figure L (Duopa 19)
An instructional illustration showing a human silhouette alongside two circular icons. The first icon depicts a medication bottle and cup, and the second icon, with a prohibition sign, shows a capsule or tablet, indicating instructions related to medication administration.*
FDA Label Image

Extra Dose Button (Duopa 1a)

FDA Label Image

Dose Screen (Duopa 1b)

Dose Screen (Duopa 1b)
A small text panel titled 'Dose' with no visible additional information or detailed dosing instructions. The panel appears to be part of a larger label or document related to drug dosing.*
FDA Label Image

Figure M (Duopa 1c)

Figure M (Duopa 1c)
An instructional diagram showing two hands opening or handling a Duopa medication delivery system, possibly a pump or dispenser device. The image illustrates the process of accessing or loading the device, with one hand holding the device and the other lifting a flap or cover.*
FDA Label Image

Figure N (Duopa 1d)

Figure N (Duopa 1d)
An instructional illustration labeled Figure N showing two hands manipulating a medical device or tubing component. One hand is holding a clip or clamp attached to a tube, and the other hand is pulling a piece of the tube or connector away, demonstrating a step in the device operation or assembly, likely related to enteral administration equipment.*
FDA Label Image

Figure O (Duopa 1e)

Figure O (Duopa 1e)
An instructional illustration showing hands assembling or connecting two small tube components with a rotating motion indicated by an arrow. The image appears to demonstrate part of the preparation or administration process for an enteral suspension product.*
FDA Label Image

Figure P (Duopa 1f)

Figure P (Duopa 1f)
An instructional illustration showing a syringe connected to a tube with clamps, likely depicting the setup or administration process for an enteral suspension medication delivery system.*
FDA Label Image

Figure Q (Duopa 20)

Figure Q (Duopa 20)
An instructional illustration showing hands assembling or preparing a medical syringe or delivery device, suggesting usage steps for administering an enteral suspension dose.*
FDA Label Image

Figure R (Duopa 21)

Figure R (Duopa 21)
An instructional diagram illustrating the assembly or connection of components related to a syringe and tubing, likely for the administration of Duopa (Carbidopa and Levodopa) enteral suspension. The diagram shows a syringe, connectors, and tubing pieces arranged sequentially for use preparation.*
FDA Label Image

Figure S (Duopa 22)

Figure S (Duopa 22)
An instructional illustration showing two hands assembling or connecting components of a device or medical apparatus, with a focus on a tube and connector. A curved arrow indicates a twisting or locking motion involved in the connection process.*
FDA Label Image

Figure-t (Duopa 23)

Figure-t (Duopa 23)
An instructional illustration showing a person holding a Duopa enteral suspension container with one hand while using the other hand to manipulate a component or accessory, indicating the proper handling or preparation of the Duopa suspension for administration.*
FDA Label Image

Figure U (Duopa 24)

Figure U (Duopa 24)
An instructional illustration depicting the Locked and Unlocked positions of a component, likely a lid or cap, on the Duopa enteral suspension delivery system. The image shows arrows indicating the direction to turn for locking and unlocking the mechanism.*
FDA Label Image

Figure V (Duopa 25)

Figure V (Duopa 25)
An instructional illustration showing a person handling a Duopa medication cassette by inserting or removing it from a holder or device, demonstrating part of the medication preparation or administration process.*
FDA Label Image

Figure W (Duopa 26)

Figure W (Duopa 26)
An instructional illustration labeled Figure W showing hands manipulating a small plastic or rubber piece, likely part of a device used with the Duopa enteral suspension. The image demonstrates how to twist or adjust a component, possibly for assembling or preparing the administration system.*
FDA Label Image

Figure X (Duopa 27)

Figure X (Duopa 27)
An instructional illustration showing a two-step connection process using hands. One hand holds a connector piece, while the other hand holds a tube, demonstrating twisting or aligning motion for assembly. This image likely relates to the administration or setup of the Duopa enteral suspension system.*
FDA Label Image

Figure Y (Duopa 28)

Figure Y (Duopa 28)
An instructional illustration showing a person holding and preparing a handheld device for use, likely associated with the administration of Duopa suspension. The image depicts one hand operating the device and another hand holding a small object, possibly a cartridge or component for the device.*
FDA Label Image

Figure Z (Duopa 29)

Figure Z (Duopa 29)
An instructional illustration showing two views of a locking mechanism labeled 'Figure Z.' The left view shows a closed, locked position on a device, with an arrow indicating the locked state. The right view shows a zoomed-in front of the locked indicator. The image likely demonstrates how to secure the locking feature on a medical delivery device.*
FDA Label Image

Figure-aa (Duopa 2a)

Figure-aa (Duopa 2a)
An instructional illustration showing a person holding a Duopa enteral suspension cartridge, with one hand steadying the cartridge and the other hand pulling a component off the top, indicated by an arrow. This image likely demonstrates part of the preparation or administration process for the Duopa suspension.*
FDA Label Image

Figure Bb (Duopa 2b)

Figure Bb (Duopa 2b)
An instructional illustration showing hands opening a rectangular container or device with a hinged lid. The image depicts the process of flipping the lid open, indicated by an arrow. The context suggests it may relate to the use or preparation of the Duopa suspension delivery system.*
FDA Label Image

Figure Cc (Duopa 2c)

Figure Cc (Duopa 2c)
An instructional illustration labeled Figure CC showing a hand holding and inserting a cartridge into a dispensing device or pump. The image depicts the connection or assembly process, likely related to the administration of a suspension product via an enteral route.*
FDA Label Image

Figure Dd (Duopa 2d)

Figure Dd (Duopa 2d)
Illustration showing a close-up of a locking mechanism for a device, labeled 'LOCKED'. The diagram uses arrows to indicate the action needed to engage or disengage the lock, likely related to the administration of Duopa suspension via an enteral route.*
FDA Label Image

Figure Ee (Duopa 2e)

Figure Ee (Duopa 2e)
An instructional illustration labeled Figure EE showing two hands connecting parts of a device or tubing by twisting or screwing them together, likely related to the administration or setup of the Duopa enteral suspension system.*
FDA Label Image

Figure Ff (Duopa 2f)

Figure Ff (Duopa 2f)
An instructional illustration depicting a hand holding a syringe and attaching or detaching a small cap or adapter to the syringe tip, suggestive of preparation for administration or dosing of a medication such as Duopa suspension.*
FDA Label Image

Figure Gg (Duopa 30)

Figure Gg (Duopa 30)
An instructional diagram showing two hands connecting parts of a medical device or tubing, likely demonstrating assembly or connection steps related to the administration device for Duopa (Carbidopa and Levodopa) enteral suspension.*
FDA Label Image

Figure Hh (Duopa 31)

Figure Hh (Duopa 31)
An instructional illustration showing hands holding and preparing a medical device, likely demonstrating how to open or set up a component such as a tube or catheter, as indicated by the arrow and close-up detail. The image is labeled as Figure HH.*
FDA Label Image

Figure Ii (Duopa 32)

Figure Ii (Duopa 32)
An illustration showing two hands assembling a medical device, with one hand holding a tube or cassette and the other hand preparing to insert it into a docking component. The figure is labeled as 'Figure 11' and likely depicts part of the setup process for an enteral suspension pump or delivery system.*
FDA Label Image

Figure Jj (Duopa 33)

Figure Jj (Duopa 33)
An instructional diagram showing a person wearing a pump device secured around their neck with straps, positioned on the chest. The illustration highlights how the enteral suspension delivery device for Duopa is worn by the patient.*
FDA Label Image

Figure Kk (Duopa 34)

Figure Kk (Duopa 34)
An instructional diagram showing a human silhouette alongside two circular icons. The first icon depicts a container with an arrow indicating administration, and the second icon shows a container with a cross mark, likely indicating an action not to be done. This image appears to illustrate usage instructions related to the Duopa suspension.*
FDA Label Image

Figure Ll (Duopa 35)

Figure Ll (Duopa 35)
An instructional illustration showing hands connecting a tube to a port or device, likely demonstrating a step in the administration or setup process for the Duopa suspension enteral delivery system.*
FDA Label Image

Figure Mm (Duopa 36)

Figure Mm (Duopa 36)
An instructional diagram labeled Figure MM, showing hands demonstrating the opening or preparation of a medical device or container, possibly related to the Duopa enteral suspension product.*
FDA Label Image

Figure Nn (Duopa 37)

Figure Nn (Duopa 37)
An instructional illustration showing a person holding a device, inserting or attaching a syringe into a port on the device, demonstrating a step in the use or administration process likely related to the Duopa suspension delivery system.*
FDA Label Image

Figure Oo (Duopa 38)

Figure Oo (Duopa 38)
An instructional illustration depicting a pair of hands manipulating a catheter or tube. One hand is holding the tube steady while the other is pulling back a small tab or cap, suggesting preparation or assembly before use.*
FDA Label Image

Up Button (Duopa 39)

FDA Label Image

Down Button (Duopa 3a)

FDA Label Image

Enter Clear Button (Duopa 3b)

FDA Label Image

Next Button (Duopa 3c)

Next Button (Duopa 3c)
An instructional illustration showing a finger pressing the "NEXT" button on a device or screen, indicating a step in a procedure or user interface navigation.*
FDA Label Image

Continuous Rate Screen (Duopa 3d)

Continuous Rate Screen (Duopa 3d)
A text panel labeled 'Continuous Rate' displaying a placeholder entry for a continuous rate infusion, with 'x.x ml/hr' indicating variable flow rate, likely related to dosage administration instructions for Duopa suspension.*
FDA Label Image

Abbvie (Duopa 3e)

FDA Label Image

Power Jack (Duopa 3f)

Power Jack (Duopa 3f)
Duopa carbidopa and levodopa enteral suspension in a clear plastic container with a white cap. The label shows product strength as 20 mg and 4.63 mg per mL, with AbbVie Inc. as the labeler. The NDC 0074-3012 is visible on the label along with dosage form details.*
FDA Label Image

Accessory Jack (Duopa 40)

FDA Label Image

Caution (Duopa 41)

FDA Label Image

Class Ii Equipment (Duopa 42)

FDA Label Image

Type Cf Equipment (Duopa 43)

FDA Label Image

Splashproof (Duopa 44)

Splashproof (Duopa 44)
Duopa 20 mg Carbidopa and 4.63 mg Levodopa per mL suspension in enteral dosage form by AbbVie Inc., NDC 0074-3012. The image shows a carton with product name, strengths, dosage form, and labeler details.*
FDA Label Image

Catalog Number (Duopa 45)

FDA Label Image

Serial Number (Duopa 46)

FDA Label Image

Manufacture Date (Duopa 47)

FDA Label Image

Manufacturer (Duopa 48)

FDA Label Image

Rx Only (Duopa 49)

FDA Label Image

Collect Separately (Duopa 4a)

FDA Label Image

Temperature Limitation (Duopa 4b)

Temperature Limitation (Duopa 4b)
An illustration showing a vertical thermometer with temperature markings, with the mercury level near the top indicating a high temperature. The image appears to be a simple temperature measurement graphic, not related to the pharmaceutical product itself.*
FDA Label Image

Humidity Limitation (Duopa 4c)

Humidity Limitation (Duopa 4c)
An illustration showing a simple schematic of a medical device setup with a circular reservoir marked with volume levels and tubing. This diagram appears to be related to enteral administration or dosing, likely corresponding to the administration method for Duopa (Carbidopa and Levodopa) suspension provided via enteral route.*
FDA Label Image

Pressure Limitation (Duopa 4d)

Pressure Limitation (Duopa 4d)
An instructional diagram illustrating the assembly or operation of a dual-connector system, showing two arrows pointing toward a central circular hub with two parallel ports. This likely represents a component in a medical device related to the administration of Duopa suspension by enteral route.*
FDA Label Image

Mr Unsafe (Duopa 4e)

FDA Label Image

Pifu-pump-diagram (Duopa 4f)

Pifu-pump-diagram (Duopa 4f)
An illustrated diagram showing the front and rear views of a CADD-Legacy 1400 device. The front view highlights features such as the display, power jack, accessory jack, AC indicator light, keypad, and medication cassette reservoir. The rear view indicates the battery compartment, cassette latch, power jack symbol, and accessory jack symbol. The diagram includes labels for each component.*
FDA Label Image

Prime (Duopa 50)

Prime (Duopa 50)
Duopa Carbidopa and Levodopa suspension, enteral dosage form, with strength 20 mg/mL and 4.63 mg/mL, manufactured by AbbVie Inc. The image shows a simple pill imprint with "PRIME" inside an oval shape, which may be part of the product's identifying marking.*
FDA Label Image

Main Screen Running (Duopa 51)

Main Screen Running (Duopa 51)
An instructional diagram showing a device display panel for Duopa, a Carbidopa and Levodopa suspension. The display indicates pump running status (RUN), reservoir volume (ResVol in ml), battery status (LowBat), and shows numeric reservoir volume measurement (nn.n ml).*
FDA Label Image

Main Screen Stopped (Duopa 52)

Main Screen Stopped (Duopa 52)
An illustration showing a status indicator of a pump with the label 'When stopped:' and the display reading 'STOPPED.' This likely pertains to the operation or status display of a medical infusion pump device.*
FDA Label Image

Install Batteries (Duopa 53)

Install Batteries (Duopa 53)
An instructional diagram showing the battery compartment of a device, illustrating the correct orientation for inserting two cylindrical batteries, with a clear indication of the positive (+) terminal placement.*
FDA Label Image

Open Battery Door (Duopa 54)

Open Battery Door (Duopa 54)
An instructional diagram showing two arrows pointing in opposite directions, likely indicating how to insert or slide a component. The illustration is simple, with one arrow pointing left and another pointing right toward or away from a component, suggesting a connection or removal step.*
FDA Label Image

Install Battery With Strap (Duopa 55)

Install Battery With Strap (Duopa 55)
An instructional illustration showing the battery compartment of a device, containing two cylindrical batteries positioned side by side with visible positive and negative terminals.*
FDA Label Image

Close Battery Door (Duopa 56)

Close Battery Door (Duopa 56)
An instructional illustration showing a close-up of a person's hands operating a device, with one hand pressing a release tab and an arrow indicating the direction to move a component, suggesting a step in preparing or using the device related to Duopa suspension administration.*
FDA Label Image

Improper Closed Battery Door (Duopa 57)

Improper Closed Battery Door (Duopa 57)
The illustration shows a medical device with three close-up views of a cartridge insertion area, each marked with a large 'X' to indicate incorrect cartridge placement or orientation.*
FDA Label Image

Combined Delivery Methods (Duopa 58)

Combined Delivery Methods (Duopa 58)
A dosage timing diagram illustrating dosing strategy over time. It shows a high initial morning dose labeled as a loading dose, followed by smaller extra doses and a continuous rate dose later in time. The vertical axis represents dosage and the horizontal axis represents time.*
FDA Label Image

Resovoirvolumescreen (Duopa 59)

Resovoirvolumescreen (Duopa 59)
An illustration of a digital display screen showing a reservoir volume readout in milliliters (mL). The display indicates 'Reservoir Volume' at the top, with a numeric value field below marked as mL, commonly used for measuring liquid medication volumes in devices such as infusion pumps.*
FDA Label Image

Contratescreen (Duopa 5a)

Contratescreen (Duopa 5a)
A drug facts text panel titled "Continuous Rate" indicating measurement units as "mL/hr" with a placeholder for numeric input. The panel appears to be related to continuous dosing rate instructions or settings, without further detailed context or information.*
FDA Label Image

Exdosescreen (Duopa 5b)

Exdosescreen (Duopa 5b)
A drug facts panel excerpt showing an 'Extra Dose' section, indicating measurement in milliliters (mL). The image contains partial text with a focus on dosage amount expressed in mL.*
FDA Label Image

Givenscreen (Duopa 5c)

Givenscreen (Duopa 5c)
This image shows a small printed text panel with the word 'Given' and adjacent medical or dosage instructions partially visible. The text appears to be part of a dosing or administration section for a drug product, likely related to timing or quantity of administration.*
FDA Label Image

Prime (Duopa 5d)

Prime (Duopa 5d)
Duopa carbidopa and levodopa enteral suspension capsule imprint logo. The capsule-shaped imprint displays the word PRIME in uppercase letters inside the outline.*
FDA Label Image

Morningdosescreen (Duopa 5e)

Morningdosescreen (Duopa 5e)
A text panel displaying dosing instructions for 'Morning Dose,' with empty fields for specifying time (h:m) and volume (mL). The panel is designed for entry of dose timing and amount for patient administration guidance.*
FDA Label Image

Attachcassette1 (Duopa 5f)

Attachcassette1 (Duopa 5f)
An instructional diagram showing a person's hands operating a Duopa infusion pump device. The illustration depicts how to hold and adjust the pump, used for delivering carbidopa and levodopa suspension via enteral route.*
FDA Label Image

Attachcassette3 (Duopa 60)

Attachcassette3 (Duopa 60)
An illustration depicting a locking mechanism on a medical device component. The image shows a cylindrical part with the word 'LOCKED' above a circular button or dial, indicating the locked position of the device part.*
FDA Label Image

Attachcassette2 (Duopa 61)

Attachcassette2 (Duopa 61)
An instructional illustration showing hands operating a small electronic device, likely a pump or infusion device, which may relate to administering Duopa suspension via an enteral route.*
FDA Label Image

Prime (Duopa 62)

FDA Label Image

Prime (Duopa 63)

Prime (Duopa 63)
Duopa 20 mg/mL and 4.63 mg/mL suspension for enteral administration. The image shows an oval-shaped tablet imprint with the text 'PRIME' in uppercase letters, likely a marker on the product packaging or delivery system. Labeler is AbbVie Inc.*
FDA Label Image

Extradosescreen (Duopa 64)

Extradosescreen (Duopa 64)
A drug facts or dosing instruction panel titled 'Extra Dose' with fields for hours (hrs) and minutes (min) to enter time information. The panel is likely part of a dosing schedule or instructions, with empty spaces for user input.*
FDA Label Image

Morningdosescreen (Duopa 65)

Morningdosescreen (Duopa 65)
A digital display panel showing a 'Morning Dose' timer, with placeholder fields for hours and minutes. The display uses a simple monochrome font on a rectangular screen background, likely intended for dosing schedule management of the Duopa suspension drug.*
FDA Label Image

Upsensorscreen (Duopa 66)

Upsensorscreen (Duopa 66)
An interface panel labeled "Upstream Sensor" with an option to toggle Off or On. The panel has a simple, rounded rectangular design with a light gray background and black text.*
FDA Label Image

Droppedorhit1 (Duopa 67)

Droppedorhit1 (Duopa 67)
Illustration showing a close-up of a locking mechanism with the word 'LOCKED' above it. The image likely relates to the Duopa suspension delivery system, depicting a locked position indicator for safe administration.*
FDA Label Image

Droppedorhit2 (Duopa 68)

Droppedorhit2 (Duopa 68)
An illustration showing a hand holding and interacting with a small, handheld electronic device featuring a display screen and two arrow buttons below it. The image appears instructional, possibly demonstrating device use or control, without specific branding or pharmaceutical details.*
FDA Label Image

Immediateflowrate (Duopa 69)

Immediateflowrate (Duopa 69)
A line chart depicting flow rate versus time (minutes) over a 120-minute duration. The graph shows fluctuating flow rate measurements ranging approximately from 2.7 to 5.6 units, with multiple oscillations between these values throughout the timeframe.*
FDA Label Image

Flowrateerror (Duopa 6a)

Flowrateerror (Duopa 6a)
A trumpet curve graph depicting percent error of flow deviation over time from minute 60 to 120. The y-axis shows deviation percentage ranging from -15 to 15, while the x-axis shows time in minutes. The graph includes curves labeled Emax, Emin, and an average deviation around -4.65%.*
FDA Label Image

Interferencesymbol (Duopa 6b)

FDA Label Image

Prime (Duopa 6c)

FDA Label Image

Stopped (Duopa 6d)

FDA Label Image

Rvnotinuse (Duopa 6e)

Rvnotinuse (Duopa 6e)
A digital display panel showing the message 'Reservoir Volume Not in Use' in black text on a light gray background. The display likely belongs to a medical device related to the administration of Duopa suspension.*
FDA Label Image

Contrate (Duopa 6f)

Contrate (Duopa 6f)
A drug facts panel showing a dosing rate section with the label 'Continuous Rate' and units of measurement in milliliters per hour (ml/hr). Specific dosage values are not visible.*
FDA Label Image

Extradoseml (Duopa 70)

Extradoseml (Duopa 70)
A text panel showing a portion labeled 'Extra Dose' with fields for entering measurement in milliliters (mL). The panel appears to be part of dosing instructions or measurement guidance for the product Duopa Carbidopa and Levodopa suspension.*
FDA Label Image

Given (Duopa 71)

Given (Duopa 71)
A digital display screen showing the word 'Given' and placeholder text 'n.n ml', indicating a measurement or dose amount, likely related to a medical or pharmaceutical device or packaging.*
FDA Label Image

Morningdose (Duopa 72)

Morningdose (Duopa 72)
A partial drug facts or dosing instruction panel showing the text 'Morning Dose' followed by blank spaces for numeric entry and volume in milliliters (ml). The rest of the panel is not visible.*
FDA Label Image

Smithslogo (Duopa 73)

FDA Label Image

Ndc 0074-3012-07 Duopa®carbidopa And Levodopaenteral Suspension 4.63 mg / 20 mg Per mL7 Cassettes (100 mL Each) This Package Not Intended Forhouseholds With Young Childreneach mL Contains 5 mg Of Carbidopa Monohydrate (equivalent To 4.63 mg Of Carbidopa Anhydrous) And 20 mg Of Levodopa. Pharmacist: Store Frozen.thaw In Refrigerator Prior To Dispensing. See Package Insert For Full Prescribing Information. Store In The Refrigerator Between 36°-46°f (2°-8°c).protect From Light.store Cassettes In The Carton Until Use.rx Only Abbvie (Duopa 74)

Ndc 0074-3012-07 Duopa®carbidopa And Levodopaenteral Suspension 4.63 mg / 20 mg Per mL7 Cassettes (100 mL Each) This Package Not Intended Forhouseholds With Young Childreneach mL Contains 5 mg Of Carbidopa Monohydrate (equivalent To 4.63 mg Of Carbidopa Anhydrous) And 20 mg Of Levodopa. Pharmacist: Store Frozen.thaw In Refrigerator Prior To Dispensing. See Package Insert For Full Prescribing Information. Store In The Refrigerator Between 36°-46°f (2°-8°c).protect From Light.store Cassettes In The Carton Until Use.rx Only Abbvie (Duopa 74)
Duopa 4.63 mg/20 mg per mL carbidopa and levodopa enteral suspension label. The package contains 7 cassettes of 100 mL each. Label includes dosing information, storage instructions to refrigerate between 36-46°F, and manufacturer AbbVie Inc., North Chicago, IL. Includes warnings and barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.